Ochre Bio
PrivateLast Round
Series A
Oct 10, 2022
Total Funding Raised
$39.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ochre Bio is a biotechnology company that develops RNA-based therapies for chronic liver diseases using a discovery platform that integrates machine learning, genomic phenotyping, and perfused human donor livers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ochre Bio Comparables
Compare Ochre Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Multiomic Health | 75% | |
| Quotient Therapeutics | 75% | |
| Insitro | 70% | |
Ochre Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 10, 2022 | ||||
| Seed | Jun 16, 2021 | ||||
| Pre Seed | Mar 18, 2020 |
Ochre Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Series A, Seed |
| LifeLink Ventures | Series A |
| Khosla Ventures | Series A, Seed |
| Hoxton Ventures | Seed |
| Hermes-Epitek | Series A, Seed |
| Lifeforce Capital | Series A |
| EIT Health | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 34% MoM, reaching 4.4K.
- Jun 30, 2025
Quin Wills appointed as the new Chief Executive Officer.
Ochre Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ochre Bio's valuation, stock price, and market status.